Crispr Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $45M | 511k | 88.00 |
| 2024-12-31 | $25M | 495k | 50.00 |
| 2024-09-30 | $41M | 632k | 65.00 |
| 2024-06-30 | $58M | 598k | 97.00 |
| 2024-03-31 | $131M | 1.1M | 121.00 |
| 2023-12-31 | $29M | 413k | 69.00 |
| 2023-09-30 | $16M | 351k | 45.39 |
| 2023-06-30 | $22M | 391k | 56.14 |
| 2022-12-31 | $21M | 508k | 40.65 |
| 2022-06-30 | $34M | 568k | 60.69 |
| 2022-03-31 | $32M | 517k | 62.66 |
| 2021-06-30 | $84M | 520k | 161.93 |
| 2020-12-31 | $112M | 731k | 153.16 |
| 2020-09-30 | $42M | 504k | 83.56 |
| 2020-06-30 | $41M | 561k | 73.49 |
| 2020-03-31 | $36M | 852k | 42.42 |
| 2019-12-31 | $16M | 255k | 60.93 |
| 2019-09-30 | $11M | 259k | 40.92 |
| 2019-03-31 | $9.6M | 269k | 35.71 |
| 2018-12-31 | $5.5M | 193k | 28.63 |
| 2018-09-30 | $10M | 233k | 44.35 |
| 2018-06-30 | $12M | 196k | 58.74 |
| 2018-03-31 | $4.4M | 97k | 45.73 |
| 2017-12-31 | $1.8M | 89k | 20.00 |
| 2017-03-31 | $449k | 21k | 21.85 |
| 2016-12-31 | $77k | 3.8k | 20.26 |